Bibliografía

PATOLOGIA VENOSA:

  1. Orbach E.J. Contributions to the therapy of the varicose complex. J Int Coll Surg 1950; 29: 765-71.
  2. Monfreux A. Traitement  sclerosant  des troncs saphéniens et leurs collaterales de gros calibre par la methode MUS. Phlébologie 2000; 129-33.
  3. Tessari L. Nouvelle technique d´obtention de la scléromousse. Phlébologie 2000; 53: 129-33.
  4. Hamel-Desnos C, Allaert FA, Benigni J, Boilette G, Chleir F, Ouvry P et al.  Polodocanol foam 3% versus 1% in the great saphenous vein: Early results. Phlebology 2005; 58: 175-82.
  5. Breu F.X., Guggenbichleir S. European Consensus meeting on foam Sclerotherapy, April 4-6, 2003, Tegermsee, Germany. Dermatol Surg 2004, 30: 709-17.
  6. Tessari L. 8º International Phlébologie Symposium, Bologna, Italy, 2006.
  7. Guex J. J. , Allaert F.A., Gillet J, Chleir F., Inmediate and midterm complications of sclerotherapy: Report of a prospective multicenter registry of 12173 sclerotherapy sessions. Dermat Surg 2005; 31: 123-8.
  8. Tessari L., Cavezzi A., Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27: 58-60.
  9. Gobin J., French experience with sclerotherapy. Angiologia E Cirigia Vascular, Ubelandia, Brazil, 2008.
  10. Jia X., Mowatt g., Burr J.M., Cassar K., Cook J., Fraser C., Sistematic review of foam sclerotherapy for varicose veins. Br J Surg 2007; 94: 925-36.
  11. Samama BM. Prévention  de la thrombose veineuse des members inférieurs. In: Priollet P., Samama M.M., Thrombose veineuse, Paris, Doin Editeurs, 1994.
  12. Laroche J.P., Righini M. Thrombose veineuse, mode d´emploi. Ed. Sauramps Medical, 2004, Montpellier.
  13. Sala Planell E, Gesto R, Jimenez Cosio JA. Epidemiologia y repercusiones sociosanitarias de la patología venosa. Estudio DETECT-IVC. An Cirug Card Vasc 2001; 7(1): 14-17.
  14. Geerts WH., Pineo G.F., Heit J.A., Bergqvist D., Lassen M.R., Colwell C.W., et al. Prevention of venous thromboembolism : the seventh ACCP conference of antithrombotic and thrombolytic therapy. Chets 2004; 1(26) (sup 3): 338S-400S.

PATOLOGIA DE LA MICROCIRCULACION:

  1. Priollet P. Acrosyndromes vasculaires. Encycl Med Chir (Elservier Paris), Dermatologie, 98-550-A-10, 1999, 10p.
  2. Roman Ivorra J A., Gonzálvez Perales JL., Fernandez Carballido C., Graña J., Torres MJ. Prevalence of Raynaud´s phenomen in general practice in the east of Spain. Clin Reumatol. 2001; 20: 88-90.
  3. Carpentier P., Satger B., Poensin D., Maricq H. Incidence andnatural history of Raynaud phenomenom:  along-term follow up (14 years) of a random sample from the general population. J Vasc Surg 2006; 44: 1032-8.
  4. Carpentier P.New techniques for clinical assessment of the peripheral microcirculation. Drugs, 1999. 58: 17-22.

PATOLOGIA ARTERIAL:

  1. Mc Gill HC., Mcmahan CA., Herderich EE et AL.Effects of coronary heart disease risk factors on atherosclerosis of  selected regions of the aorta and right coronary artery: PDAY research group, Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Tromb Vasc Biol 2000; 20: 836-45.
  2. Virmani R, Burke AP., Farb A., Kolodgie F D. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47: C13-8.
  3. Greenland P, Abrams J, Aurigemma GP et AL. Prevention conference V: beyong secondary prevention , identifying the high – risk patient for primary prevention , non invasive tests of athero-sclerotic burden. Circulation 2000; 101: E16-22.

PATOLOGIA LINFATICA

  1. Brunner U et Coll. Epidemiology and clinic of primary lymphoedema exemplified by 5oo cases. The Initial Lymphatics, Ed a. Bolinger, H Partsch., j.H.N Wolfe Gerog Thiele Verlag 1985: 7-14.
  2. Coupé M et Coll.. Vivre mieux le lymphoèdeme . Livre 7 Cd- Forums, 6º Journées Nationales de l´AFFCA , Montpellier  1999, 261-305.
  3. Janbon Ch., Soulier Sotto V. Lymphoedeme primaire . Encycl Med Chir (Elservier, Paris), Angéiologie, 19-3010, 1997, 7p.
  4. Janbon Ch.,Lymphologie. Collecttion de Médecine Vasculaire, Nº3, 1994, 200p, 83 figures, Editions Lasson.

 

volver atrás
Enlaces:   Consulta médica autorizada por la Generalitat de Catalunya   Web Médica Acreditada. Ver más información               Doctoralia es la plataforma líder mundial que conecta profesionales de la salud con pacientes, transformando y mejorando la relación entre ellos           
Aviso Legal